PharmaResearch Co., Ltd. (KOSDAQ:214450)
349,500
-500 (-0.14%)
Apr 2, 2025, 3:30 PM KST
PharmaResearch Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 1, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Market Capitalization | 3,636,377 | 2,727,283 | 1,116,952 | 697,316 | 818,025 | 552,155 | Upgrade
|
Market Cap Growth | 144.17% | 144.17% | 60.18% | -14.76% | 48.15% | 60.62% | Upgrade
|
Enterprise Value | 3,438,531 | 2,575,782 | 990,868 | 612,568 | 761,136 | 536,011 | Upgrade
|
Last Close Price | 350000.00 | 262500.00 | 109041.14 | 68996.50 | 80178.04 | 55527.18 | Upgrade
|
PE Ratio | 39.15 | 29.63 | 14.59 | 17.18 | 17.52 | 16.85 | Upgrade
|
Forward PE | 27.30 | 22.06 | 12.55 | 10.92 | 14.49 | 15.04 | Upgrade
|
PS Ratio | 10.29 | 7.79 | 4.28 | 3.58 | 5.31 | 5.08 | Upgrade
|
PB Ratio | 6.74 | 4.78 | 2.42 | 1.88 | 2.49 | 2.09 | Upgrade
|
P/TBV Ratio | 5.38 | 5.38 | 2.77 | 2.27 | 3.10 | 2.67 | Upgrade
|
P/FCF Ratio | 35.75 | 26.82 | 21.12 | 16.55 | 18.32 | - | Upgrade
|
P/OCF Ratio | 19.75 | 19.75 | 17.20 | 11.74 | 12.53 | 17.05 | Upgrade
|
EV/Sales Ratio | 9.82 | 7.36 | 3.80 | 3.15 | 4.94 | 4.93 | Upgrade
|
EV/EBITDA Ratio | 24.61 | 18.44 | 9.50 | 8.01 | 12.27 | 12.83 | Upgrade
|
EV/EBIT Ratio | 27.28 | 20.43 | 10.74 | 9.29 | 14.50 | 16.04 | Upgrade
|
EV/FCF Ratio | 33.81 | 25.33 | 18.74 | 14.53 | 17.05 | - | Upgrade
|
Debt / Equity Ratio | 0.37 | 0.37 | 0.07 | 0.18 | 0.20 | 0.12 | Upgrade
|
Debt / EBITDA Ratio | 1.49 | 1.49 | 0.33 | 0.87 | 1.06 | 0.78 | Upgrade
|
Debt / FCF Ratio | 2.05 | 2.05 | 0.65 | 1.58 | 1.47 | - | Upgrade
|
Asset Turnover | 0.50 | 0.50 | 0.52 | 0.43 | 0.41 | 0.37 | Upgrade
|
Inventory Turnover | 1.84 | 1.84 | 1.90 | 2.55 | 2.40 | 2.07 | Upgrade
|
Quick Ratio | 5.84 | 5.84 | 2.96 | 4.04 | 3.86 | 2.87 | Upgrade
|
Current Ratio | 6.75 | 6.75 | 3.89 | 4.56 | 4.31 | 3.55 | Upgrade
|
Return on Equity (ROE) | 17.23% | 17.23% | 18.53% | 12.41% | 15.80% | 13.17% | Upgrade
|
Return on Assets (ROA) | 11.33% | 11.33% | 11.38% | 9.10% | 8.78% | 7.08% | Upgrade
|
Return on Capital (ROIC) | 12.35% | 12.35% | 12.34% | 9.90% | 9.50% | 7.65% | Upgrade
|
Return on Capital Employed (ROCE) | 16.30% | 16.30% | 19.70% | 15.60% | 13.80% | 11.80% | Upgrade
|
Earnings Yield | 2.53% | 3.38% | 6.85% | 5.82% | 5.71% | 5.94% | Upgrade
|
FCF Yield | 2.80% | 3.73% | 4.74% | 6.04% | 5.46% | -0.43% | Upgrade
|
Dividend Yield | 0.33% | 0.42% | 0.87% | 0.96% | 0.75% | 0.90% | Upgrade
|
Payout Ratio | 10.96% | 10.96% | 9.84% | 15.56% | 10.77% | 9.04% | Upgrade
|
Buyback Yield / Dilution | 2.50% | 2.50% | -5.85% | 0.76% | -5.74% | -0.73% | Upgrade
|
Total Shareholder Return | 2.83% | 2.92% | -4.97% | 1.72% | -4.99% | 0.17% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.